MedPath
TGA Approval

AXIO LO (391753)

391753

AXIO LO

LifeVantage Australia Pty Ltd

July 4, 2022

Medicine

Medicine

Active

Listed

Active Ingredients

Camellia sinensis

magnesium chloride hexahydrate

nicotinamide

pyridoxine hydrochloride

Asparagus officinalis

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXIO LO (391753) - TGA 批准文号 | MedPath